美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Alamar Biosciences, Inc.

17.00

0.0000

成交量：- -

成交额：- -

市值：11.03亿

市盈率：-6.87

高：- -

开：- -

低：- -

收：17.00

52周最高：- -

52周最低：- -

股本：6,489.08万

流通股本：937.50万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.4751

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Alamar Biosciences, Inc.

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.alamarbio.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Alamar Biosciences, Inc.于2018年5月7日在特拉华州注册成立，总部位于加利福尼亚州弗里蒙特市。该公司是一家商业化阶段的蛋白质组学公司，致力于建立蛋白质检测和分析的黄金标准。公司提供专有的NULISA平台，该平台能够以超高灵敏度、高特异性、灵活的多重检测、宽动态范围和自动化，检测非侵入性生物体液中的低丰度蛋白质生物标志物，从而实现“精准蛋白质组学”。公司提供仪器、耗材和分析软件的集成解决方案，用于发现、转化研究和诊断开发。

董事

名称

职位

Yuling Luo

Chief Executive Officer and Chairman

Shiping Chen

Chief Operating Officer and Director

Frank R. Witney

Director

Ian W. Ratcliffe

Director

Nicholas Naclerio

Director

Rebecca Chambers

Director

股东

名称

职位

Yuling Luo

Chief Executive Officer and Chairman

Shiping Chen

Chief Operating Officer and Director

Justin McAnear

Chief Financial Officer

Timothy White

President

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ALMR/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALMR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMR\",,,,,undefined,":{"symbol":"ALMR","market":"US","secType":"STK","nameCN":"Alamar Biosciences, Inc.","latestPrice":17,"timestamp":1776369600000,"preClose":17,"halted":9,"volume":0,"delay":0,"changeRate":0,"floatShares":9375000,"shares":64890799,"eps":-2.475102,"marketStatus":"待开盘","change":0,"latestTime":"04-16 16:00:00 EDT","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.475102,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776432600000},"marketStatusCode":16,"adr":0,"listingDate":1776398400000,"exchange":"NASDAQ","adjPreClose":17,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMR\",,,,,undefined,":{"symbol":"ALMR","floatShares":9375000,"roa":"--","roe":"--","lyrEps":0,"shares":64890799,"dividePrice":0,"high":0,"amplitude":0,"preClose":17,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":17,"eps":-2.475102,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.475102,"open":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALMR\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALMR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALMR\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.alamarbio.com","compareEarnings":[{"period":"1week","weight":0.0354},{"period":"1month","weight":0.0462},{"period":"3month","weight":0.0111},{"period":"6month","weight":0.0535},{"period":"1year","weight":0.3019},{"period":"ytd","weight":0.0264}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Alamar Biosciences, Inc.于2018年5月7日在特拉华州注册成立，总部位于加利福尼亚州弗里蒙特市。该公司是一家商业化阶段的蛋白质组学公司，致力于建立蛋白质检测和分析的黄金标准。公司提供专有的NULISA平台，该平台能够以超高灵敏度、高特异性、灵活的多重检测、宽动态范围和自动化，检测非侵入性生物体液中的低丰度蛋白质生物标志物，从而实现“精准蛋白质组学”。公司提供仪器、耗材和分析软件的集成解决方案，用于发现、转化研究和诊断开发。","exchange":"NASDAQ","name":"Alamar Biosciences, Inc.","nameEN":"Alamar Biosciences"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ALMR\",market:\"US\",,,undefined,":{"directors":[{"name":"Yuling Luo","position":"Chief Executive Officer and Chairman"},{"name":"Shiping Chen","position":"Chief Operating Officer and Director"},{"name":"Frank R. Witney","position":"Director"},{"name":"Ian W. Ratcliffe","position":"Director"},{"name":"Nicholas Naclerio","position":"Director"},{"name":"Rebecca Chambers","position":"Director"}],"executives":[{"name":"Yuling Luo","position":"Chief Executive Officer and Chairman"},{"name":"Shiping Chen","position":"Chief Operating Officer and Director"},{"name":"Justin McAnear","position":"Chief Financial Officer"},{"name":"Timothy White","position":"President"}]}}}